CLINICAL_TRIALS trial_result · 2023-04-24

Clinical Trial Update: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression [Phase 2]

Phase 2 trial update on the safety and efficacy of psilocybin in treatment-resistant depression; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: COMPASS Pathways | Conditions: Treatment Resistant Depression | Phase 2 | Status: COMPLETED | Results posted: 2023-04-24